Company: APXIF
Filing Date: 2025-01-22
Form Type: F-4
Source: 0001213900-25-005463
Chunk: 8

Company: APx Acquisition Corp. I
Filing Date: 2025-01-22
Form: F-4
Chunk 8
---
 to have a compensation

committee and a nominating and governance committee, although we expect to establish a compensation committee and a nominating and governance committee, the majority of which may consist of independent directors. We have decided to be treated as a “controlled company” and, even though three members of our board of directors and a majority of the members of our compensation committee and our nominating and governance committee (that we chose to establish) are expected to consist of independent directors, you may not have the same protections afforded to shareholders of companies that are subject to all of the Nasdaq corporate governance requirements. See “ Risk Factors — Additional Risks Related to the Business Combination — Following the closing of the Business Combination, we will be a “controlled company” as defined in the Nasdaq rules and, as a result, qualify for exemptions from certain corporate governance requirements.” Compensation Received by the Sponsors

|                 |     | Interest in Securities                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |     | Other Compensation                                                                                                                                                                                                                                                                                                                                                     |
| Sponsor         |     | At Closing, Sponsor shall deliver for cancellation 3,342,188 Founder Shares; and upon the completion of the Business Combination, Sponsor shall hold a total of 3,342,188 Company Shares. The Sponsor paid $50,001 (comprised of $1 in cash to the Initial Sponsor, and a commitment of $50,000 to fund APx’s Exchange Act reporting obligations), approximately $0.015 per share, to purchase 3,342,188 Founder Shares. Based on the closing price of the Public Shares of $         on the Record Date, the Sponsor could earn a return of $         per share, or $         in the aggregate, upon the sale of its Founder Shares, corresponding to a rate of return of         %. If the Closing occurs, such shares shall be converted into Company Shares and retained by the Sponsor. If APx does not complete an initial business combination, such shares will expire worthless. See “Questions and Answers about the Business Combination and the Special Meeting — What equity stake will our current shareholders and shareholders of the Target hold in OmnigenicsAI immediately after consummation of the Business Combination?”, “Unaudited Pro Forma Combined Consolidated Financial Information — Basis of Presentation,” and “Comparative Per Share Data.”                                            |     | Pursuant to the terms of the Business Combination Agreement, the reasonable and documented out-of-pocket fees and expenses payable by APx as a result of, in relation to or in connection with AP